DNAJB5 Antibody
-
中文名稱：DNAJB5兔多克隆抗體
-
貨號：CSB-PA007011LA01HU
-
規格：￥440
-
圖片：
-
Western Blot
Positive WB detected in: HepG2 whole cell lysate
All lanes: DNAJB5 antibody at 3.2µg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 40, 48, 52 kDa
Observed band size: 48 kDa -
Immunohistochemistry analysis of human glioma using CSB-PA007011LA01HU at dilution of 1:100
-
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) DNAJB5 Polyclonal antibody
-
Uniprot No.：
-
基因名：DNAJB5
-
別名：DnaJ (Hsp40) homolog subfamily B member 5 antibody; DnaJ homolog subfamily B member 5 antibody; DNAJB5 antibody; DNJB5_HUMAN antibody; Heat shock cognate 40 antibody; Heat shock protein cognate 40 antibody; Heat shock protein Hsp40 2 antibody; Heat shock protein Hsp40 3 antibody; Heat shock protein Hsp40-2 antibody; Heat shock protein Hsp40-3 antibody; Hsc40 antibody; Hsp40 2 antibody; KIAA1045 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human DnaJ homolog subfamily B member 5 protein (1-344AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
本頁面中的產品，DNAJB5 Antibody (CSB-PA007011LA01HU)，的標記方式是Non-conjugated。對于DNAJB5 Antibody，我們還提供其他標記。見下表：
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA, WB, IHC
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:5000 IHC 1:20-1:200 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
Most popular with customers
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
-
